The feasibility of single-port laparoscopic appendectomy using a solo approach: a comparative study.
10.4174/astr.2016.90.3.164
- Author:
Say June KIM
1
;
Byung Jo CHOI
;
Wonjun JEONG
;
Sang Chul LEE
Author Information
1. Department of Surgery, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Korea. zambo9@catholic.ac.kr
- Publication Type:Comparative Study ; Original Article
- Keywords:
Appendectomy;
Laparoscopic camera holder;
Single port laparoscopic surgery;
Solo surgeon
- MeSH:
Analgesics;
Appendectomy*;
Hospital Costs;
Humans;
Incidence;
Postoperative Complications;
Prospective Studies;
Retrospective Studies
- From:Annals of Surgical Treatment and Research
2016;90(3):164-170
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: To investigate the feasibility and safety of solo surgery with single-port laparoscopic appendectomy, which is termed herein solo-SPLA (solo-single-port laparoscopic appendectomy). METHODS: This study prospectively collected and retrospectively analyzed data from patients who had undergone either non-solo-SPLA (n = 150) or solo-SPLA (n = 150). Several devices were utilized for complete, skin-to-skin solo-SPSA, including a Lone Star Retractor System and an adjustable mechanical camera holder. RESULTS: Operating times were not significantly different between solo- and non-solo-SPLA (45.0 +/- 21.0 minutes vs. 46.7 +/- 26.1 minutes, P = 0.646). Most postoperative variables were also comparable between groups, including the necessity for intravenous analgesics (0.7 +/- 1.2 ampules [solo-SPLA] vs. 0.9 +/- 1.5 ampules [non-solo-SPLA], P = 0.092), time interval to gas passing (1.3 +/- 1.0 days vs. 1.4 +/- 1.0 days, P = 0.182), and the incidence of postoperative complications (4.0% vs. 8.7%, P = 0.153). Moreover, solo-SPLA effectively lowered the operating cost by reducing surgical personnel expenses. CONCLUSION: Solo-SPLA economized staff numbers and thus lowered hospital costs without lengthening of operating time. Therefore, solo-SPLA could be considered a safe and feasible alternative to non-solo-SPLA.
